territrem b has been researched along with thioflavin t in 1 studies
| Studies (territrem b) | Trials (territrem b) | Recent Studies (post-2010) (territrem b) | Studies (thioflavin t) | Trials (thioflavin t) | Recent Studies (post-2010) (thioflavin t) |
|---|---|---|---|---|---|
| 25 | 0 | 5 | 74 | 17 | 5 |
| Protein | Taxonomy | territrem b (IC50) | thioflavin t (IC50) |
|---|---|---|---|
| tumor necrosis factor | Homo sapiens (human) | 0.762 | |
| nucleotide-binding oligomerization domain-containing protein 1 isoform 1 | Homo sapiens (human) | 0.556 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rashid, ZF; Beri, V; Cheung, J; Rosenberry, TL; Shiomi, K; Wildman, SA | 1 |
1 other study(ies) available for territrem b and thioflavin t
| Article | Year |
|---|---|
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Topics: Acetylcholine; Acetylcholinesterase; Aflatoxin B1; Binding Sites; Binding, Competitive; Catalysis; Catalytic Domain; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Humans; Hydrolysis; Kinetics; Models, Chemical; Phenanthrenes; Pyrans; Quinones; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2013 |